ISSN: 2572-4118

Breast Cancer: Current Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Breast Can Curr Res 2023, Vol 8(5): 5
  • DOI: 10.4172/2572-4118.1000214

Breast Cancer Stem Cell Antigens as Immunotherapeutic Targets

Laura Cavallo*
Department of Molecular Biotechnology and Health Science, Italy
*Corresponding Author : Laura Cavallo, Department of Molecular Biotechnology and Health Science, Italy, Email: l.cavallo@unito.it

Received Date: Oct 01, 2023 / Published Date: Oct 30, 2023

Abstract

Breast cancer remains a significant global health challenge, demanding innovative approaches to enhance treatment outcomes. Among these approaches, immunotherapy has gained significant attention. This thesis explores the concept of immunotherapeutic targeting of breast cancer stem cell (BCSC) antigens as a promising strategy to combat the complexities of breast cancer. It comprehensively reviews the current state of knowledge, recent developments, challenges, and future directions in this dynamic field. The thesis begins with an introduction outlining the significance of breast cancer and the critical role of BCSCs in tumor initiation, progression, and recurrence. It then sets forth the objectives, including a comprehensive literature review of BCSC-specific antigens as immunotherapeutic targets, an assessment of the current status of BCSC-specific immunotherapies, an exploration of challenges and potential solutions, and an examination of future directions and their implications for breast cancer treatment. The subsequent chapters delve into specific BCSC-specific antigens, such as CD44, ALDH1, and EpCAM, elucidating their roles in BCSC biology and their potential as targets for immunotherapy. The review encompasses preclinical and clinical studies targeting these antigens, shedding light on their promise and limitations. Challenges in BCSC-specific immunotherapy are discussed comprehensively, including tumor heterogeneity, resistance mechanisms, and the intricacies of clinical translation. Strategies for addressing these challenges, such as personalized medicine approaches and combination therapies, are proposed. The thesis concludes with an exploration of future directions in BCSC-specific immunotherapy, emphasizing the potential of combination therapies, the development of personalized treatment approaches, and the necessity of ongoing clinical trials. It underscores the significance of rigorous research in advancing BCSC-specific immunotherapies and its broader implications for cancer immunotherapy as a whole.

Citation: Cavallo L (2023) Breast Cancer Stem Cell Antigens as ImmunotherapeuticTargets. Breast Can Curr Res 8: 214. Doi: 10.4172/2572-4118.1000214

Copyright: © 2023 Cavallo L. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top